Modified protocol for in vivo imaging of wild-type mouse retina with customized miniature spectral domain optical coherence tomography (SD-OCT) device
© Ferguson et al.; licensee BioMed Central Ltd. 2012
Received: 11 July 2012
Accepted: 6 October 2012
Published: 11 October 2012
This protocol outlines and evaluates a modified scanning procedure for a customized spectral domain optical coherence tomography (SD-OCT) imaging apparatus within the wild-type C57Bl/6 mouse posterior segment. This modified protocol allows for the capture of a 50 degree field of view spanning 3 mm by 3 mm perimeter with the optic disc as the central point. By utilizing this scanning protocol a more reliable measurement of retinal thickness can be achieved outside the fluctuating region of the optic disc. This protocol, when applied to this high resolution device, enables non-invasive in vivo histological imaging and biometric assessment of the various layers of the rodent posterior segment within a 20 – 30 min procedural time-frame. This protocol could establish a standardized method for evaluating morphological changes, with this commercial SDOCT device, when assessing longitudinal disease pathophysiology and treatment response in mouse models for future vision science research.
KeywordsSpectral domain optical coherence tomography Customized Retinal imaging Mouse
Mouse models represent valuable paradigms for studying retinal neurodegenerative and vascular disorders that are analogous in humans. By characterizing the natural course of pathological change evident in these models, information pertaining to morphology and function can be ascertained for individual diseases. Mouse models have been instrumental for understanding pathophysiology in a variety of retinal diseases including: retinopathy of prematurity , diabetic retinopathy [2–4], exudative age-related macular degeneration , retinal vascular occlusion and ischemia-reperfusion injury models  and inherited retinal diseases [7–11].
The gold standard approach for studying retinal disease changes in these animal models has been through the use of ex vivo histological preparations after sacrificing the animal. This methodology is fraught with limitations as it provides one time observation and includes tissue damage, toxicity, laborious technical procedures, as well as tangential assessment of disease pathophysiology. In vivo techniques such as fundoscopy, confocal scanning laser ophthalmoscopy (cSLO), angiography, and electroretinography (ERG) allow longitudinal observation of dynamic functional and morphological changes within disease models, but do not provide histological evidence.
SD-OCT provides rapid, high resolution, cross-sectional images almost resembling histology images and assist in the diagnosis of posterior segment pathology at various time points [12, 13]. Because of this ability to acquire high-definition cross-sectional images of the retina, in humans, SD-OCT machines are being increasingly used in clinical practice. SD-OCT has been applied to investigate degenerative conditions not only in humans but also other animal species [14–17]. SD-OCT provides histological – grade sections of the rodent posterior segment non-invasively. However, acquisition of images in animals is cumbersome as machines are specifically designed for human use.
In this report, we describe a modified scanning protocol for a stereotactic rotational multidirectional animal containment apparatus, with SD-OCT imaging capabilities, for the acquisition of high resolution scans of the ocular posterior segment in mice. Our objective was to evaluate the implementation of a modified scanning protocol on a commercially available miniature SD-OCT device customized for rodent retinal imaging. Current use of this SD-OCT apparatus relies on scanning protocols that isolate retinal areas only pertaining to scanning region of approximately 1.5 mm by 1.5 mm [18, 19]. Anatomically, this represents sections of greater thickness fluctuations as the retina begins to bottleneck with the emergence of the optic disc at the posterior pole. In order to measure a more uniform retinal region, measurements taken outside this central subfield (CSF) area would permit for a more accurate determination of retinal thickness. In our study we implemented a scanning protocol which delineated the CSF area in order to assess retinal thickness from more uniform regions of the posterior segment.
Results and discussion
The Bioptigen spectral domain ophthalmic imaging system (SDOIS) represents an alternative non-invasive in vivo imaging device which achieves high resolution histological – grade cross-sections along with en-face retinal imaging for the purposes of amassing volume intensity projection scans. The SDOIS possesses comparable axial resolution depths as observed with other high resolution OCT devices [14, 15, 18–21]. The use of this specific setup, along with the customized scanning protocol designed to capture full-field fundus images and cross-sectional views of the posterior segment, permits the acquisition of real-time SD-OCT scans of retinal morphology.
In summary, this protocol details the animal and ophthalmic preparatory procedures as well as optimized technical method for acquiring retinal scans with the SDOIS. The imaging procedures as outlined in this protocol can be employed to assess normal mouse retinal anatomy along with rodent ocular disease model morphology when operating the SDOIS AIM-RAS setup.
Materials and supplies
Three adult C57Bl/6 mice (Jackson Laboratory, Bar Harbor, ME) were utilized for this study. All experiments were performed in accordance with the University of Florida institutional animal care and use committee guidelines and adhered to The Code of Ethics of the World Medical Association (Declaration of Helsinki) for animal experiments. The mice were housed and maintained in the University of Florida animal care services (ACS) facility and subjected to a 12-hour light/dark cycle with constant access to nourishments. All scanning and preparatory procedures were conducted in an ACS designated and approved procedural location.
Ketamine (Ketaject, 100 mg/mL, 80 mg/kg body weight) and Xylazine (Ana Sed, 100 mg/mL, 10 mg/kg body weight) anesthetics were purchased from Webster Veterinary (Devens, MA). Sterile NaCl 0.9% (wt/vol) was used in addition to Ketamine and Xylazine for creation of the anesthetic mixture. The Ketamine (16 mg/mL) and Xylazine (2 mg/mL) anesthesia stock reagents were diluted in sterile 0.9% NaCl solution. Mice were anesthetized by means of i.p. injection of Ketamine/Xylazine mixture. Afterwards, the animals were placed onto a 37°C thermostatic heating pad while in a sternally recumbent position. Once the mice were deemed fully anesthetized, one drop of dilating agent was applied for 2 – 3 minutes bilaterally. The dilating solution was wicked away and one drop of artificial tear was added to each eye to prevent corneal desiccation. Mydriasis was achieved with use of Tropicamide 1% (Akorn Inc.; Lake Forest, IL) while corneal hydration was maintained with Systane Ultra® lubricant eye drops (Alcon, Fort Worth, TX).
Imaging and animal equipment
SD-OCT imaging of ONH and retina
After the HHP lens was situated close to the right eye of the animal, the InVivoVue Clinic application was activated and the scanning began- following setup of subject profile for image acquisition. We selected the rectangular scanning protocol consisting of a 3 mm by 3 mm perimeter with 1000 A-scans per B-scan with a total B-scan amount of 100. This is a modification of the recommended parameters of 1.4 mm by 1.4 mm set by the company for performing rectangular scans.
In order to bring the ONH into view and focus we made fine tune adjustments to the animal cassette. At this point the eye was docked into the aiming target, and the ONH was centered within the viewing pane, of the InVivoVue Clinic application, for the B-scan and the en face images of the retina. We fine-tuned B-scan focusing by adjusting the Z-translator on the AIM, which moved the HHP towards or away from the eye, and also by dialing the reference arm on the base system in order to obtain bright crisp B-scan images. The CSF was defined as the central 1 mm area containing the ONH. This region was demarcated by using the InvVivoVue Clinic measurement calipers to establish the 1 mm diameter area from the center of the ONH. Thickness measurements were performed with the caliper instruments outside the CSF area.
Statistical analyses included the mean and range for each of the posterior segment layers in the three animals examined. A one-way analysis of variance was performed to contrast layer thickness between the three animals. Statistical significance was achieved if the two tailed p-value was less than the alpha level of 0.05.
We like to thank James M. Dominguez, Lynn Shaw, and Maria Grant for providing access to animal subjects and use of their laboratory facilities.
- Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA: Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci. 1994, 35 (1): 101-111.PubMedGoogle Scholar
- Kern TS, Engerman RL: A mouse model of diabetic retinopathy. Arch Ophthalmol. 1996, 114 (8): 986-990. 10.1001/archopht.1996.01100140194013.View ArticlePubMedGoogle Scholar
- Feit-Leichman RA, Kinouchi R, Takeda M, Fan Z, Mohr S, Kern TS, Chen DF: Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Invest Ophthalmol Vis Sci. 2005, 46 (11): 4281-4287. 10.1167/iovs.04-1361.View ArticlePubMedGoogle Scholar
- Zheng L, Du Y, Miller C, Gubitosi-Klug RA, Ball S, Berkowitz BA, Kern TS: Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Diabetologia. 2007, 50 (9): 1987-1996. 10.1007/s00125-007-0734-9.View ArticlePubMedGoogle Scholar
- Aguilar E, Dorrell MI, Friedlander D, Jacobson RA, Johnson A, Marchetti V, Moreno SK, Ritter MR, Friedlander M: Chapter 6. Ocular models of angiogenesis. Methods Enzymol Volume 444. Edited by: Cheresh DA. 2008, New York: Elsevier Inc, 115-158.Google Scholar
- Grant MB, May WS, Caballero S, Brown GA, Guthrie SM, Mames RN, Byrne BJ, Vaught T, Spoerri PE, Peck AB, Scott EW: Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med. 2002, 8 (6): 607-612. 10.1038/nm0602-607.View ArticlePubMedGoogle Scholar
- Karan G, Lillo C, Yang Z, Cameron DJ, Locke KG, Zhao Y, Thirumalaichary S, Li C, Birch DG, Vollmer-Snarr HR, Williams DS, Zhang K: Lipofuscin accumulation, abnormal electrophysiology, and photoreceptor degeneration in mutant ELOVL4 transgenic mice: a model for macular degeneration. Proc Natl Acad Sci U S A. 2005, 102 (11): 4164-4169. 10.1073/pnas.0407698102.PubMed CentralView ArticlePubMedGoogle Scholar
- Pang JJ, Chang B, Hawes NL, Hurd RE, Davisson MT, Li J, Noorwez SM, Malhotra R, McDowell JH, Kaushal S, Hauswirth WW, Nusinowitz S, Thompson DA, Heckenlively JR: Retinal degeneration 12 (rd12): a new, spontaneously arising mouse model for human Leber congenital amaurosis (LCA). Mol Vis. 2005, 11: 152-162.PubMedGoogle Scholar
- Pittler SJ, Baehr W: Identification of a nonsense mutation in the rod photoreceptor cGMP phosphodiesterase beta-subunit gene of the rd mouse. Proc Natl Acad Sci U S A. 1991, 88 (19): 8322-8326. 10.1073/pnas.88.19.8322.PubMed CentralView ArticlePubMedGoogle Scholar
- Radu RA, Mata NL, Bagla A, Travis GH: Light exposure stimulates formation of A2E oxiranes in a mouse model of Stargardt's macular degeneration. Proc Natl Acad Sci U S A. 2004, 101 (16): 5928-5933. 10.1073/pnas.0308302101.PubMed CentralView ArticlePubMedGoogle Scholar
- Weber BH, Schrewe H, Molday LL, Gehrig A, White KL, Seeliger MW, Jaissle GB, Friedburg C, Tamm E, Molday RS: Inactivation of the murine X-linked juvenile retinoschisis gene, Rs1h, suggests a role of retinoschisin in retinal cell layer organization and synaptic structure. Proc Natl Acad Sci U S A. 2002, 99 (9): 6222-6227. 10.1073/pnas.092528599.PubMed CentralView ArticlePubMedGoogle Scholar
- Alam S, Zawadzki RJ, Choi S, Gerth C, Park SS, Morse L, Werner JS: Clinical application of rapid serial fourier-domain optical coherence tomography for macular imaging. Ophthalmology. 2006, 113 (8): 1425-1431. 10.1016/j.ophtha.2006.03.020.PubMed CentralView ArticlePubMedGoogle Scholar
- Wojtkowski M, Srinivasan V, Fujimoto JG, Ko T, Schuman JS, Kowalczyk A, Duker JS: Three-dimensional retinal imaging with high-speed ultrahigh-resolution optical coherence tomography. Ophthalmology. 2005, 112 (10): 1734-1746. 10.1016/j.ophtha.2005.05.023.PubMed CentralView ArticlePubMedGoogle Scholar
- Fischer MD, Huber G, Beck SC, Tanimoto N, Muehlfriedel R, Fahl E, Grimm C, Wenzel A, Remé CE, van de Pavert SA, Wijnholds J, Pacal M, Bremner R, Seeliger MW: Noninvasive, in vivo assessment of mouse retinal structure using optical coherence tomography. PLoS One. 2009, 4 (10): e7507-10.1371/journal.pone.0007507.PubMed CentralView ArticlePubMedGoogle Scholar
- Huber G, Beck SC, Grimm C, Sahaboglu-Tekgoz A, Paquet-Durand F, Wenzel A, Humphries P, Redmond TM, Seeliger MW, Fischer MD: Spectral domain optical coherence tomography in mouse models of retinal degeneration. Invest Ophthalmol Vis Sci. 2009, 50 (12): 5888-5895. 10.1167/iovs.09-3724.PubMed CentralView ArticlePubMedGoogle Scholar
- Srinivasan VJ, Ko TH, Wojtkowski M, Carvalho M, Clermont A, Bursell SE, Song QH, Lem J, Duker JS, Schuman JS, Fujimoto JG: Noninvasive volumetric imaging and morphometry of the rodent retina with high-speed, ultrahigh-resolution optical coherence tomography. Invest Ophthalmol Vis Sci. 2006, 47 (12): 5522-5528. 10.1167/iovs.06-0195.PubMed CentralView ArticlePubMedGoogle Scholar
- Wolf-Schnurrbusch UE, Enzmann V, Brinkmann CK, Wolf S: Morphologic changes in patients with geographic atrophy assessed with a novel spectral OCT-SLO combination. Invest Ophthalmol Vis Sci. 2008, 49 (7): 3095-3099. 10.1167/iovs.07-1460.View ArticlePubMedGoogle Scholar
- Pennesi ME, Michaels KV, Magee SS, Maricle A, Davin SP, Garg AK, Gale MJ, Tu DC, Wen Y, Erker LR, Francis PJ: Long-Term Characterization of Retinal Degeneration in rd1 and rd10 Mice Using Spectral Domain Optical Coherence Tomography. Invest Ophthalmol Vis Sci. 2012, 10;53 (8): 4644-4656.View ArticleGoogle Scholar
- Kagemann L, Wollstein G, Ishikawa H, Nadler Z, Sigal IA, Folio LS, Schuman JS: Visualization of the conventional outflow pathway in the living human eye. Ophthalmology. 2012, 119 (8): 1563-1568. 10.1016/j.ophtha.2012.02.032.PubMed CentralView ArticlePubMedGoogle Scholar
- Fukuchi T, Takahashi K, Shou K, Matsumura M: Optical coherence tomography (OCT) findings in normal retina and laser-induced choroidal neovascularization in rats. Graefes Arch Clin Exp Ophthalmol. 2001, 239 (1): 41-46. 10.1007/s004170000205. Erratum in: Graefes Arch Clin Exp Ophthalmol 2001, 239(5):387View ArticlePubMedGoogle Scholar
- Ruggeri M, Wehbe H, Jiao S, Gregori G, Jockovich ME, Hackam A, Duan Y, Puliafito CA: In vivo three-dimensional high-resolution imaging of rodent retina with spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2007, 48 (4): 1808-1814. 10.1167/iovs.06-0815.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.